Mateo J, Smith A, Ong M, de Bono JS: Novel drugs targeting the androgen receptor pathway in prostate cancer. Cancer metastasis reviews. 2014, doi:10.1007/s10555-013-9472-2
Google Scholar
Taplin ME: Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clin Pract Oncology. 2007, 4 (4): 236-244. 10.1038/ncponc0765.
Article
CAS
Google Scholar
Knudsen KE, Penning TM: Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab. 2010, 21 (5): 315-324. 10.1016/j.tem.2010.01.002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bradbury RH, Acton DG, Broadbent NL, Brooks AN, Carr GR, Hatter G, Hayter BR, Hill KJ, Howe NJ, Jones RD, Jude D, Lamont SG, Loddick SA, McFarland HL, Parveen Z, Rabow AA, Sharma-Singh G, Stratton NC, Thomason AG, Trueman D, Walker GE, Wells SL, Wilson J, Wood JM: Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer. Bioorg Med Chem Lett. 2013, 23 (7): 1945-1948. 10.1016/j.bmcl.2013.02.056.
Article
CAS
PubMed
Google Scholar
Bradbury RH, Hales NJ, Rabow AA, Walker GE, Acton DG, Andrews DM, Ballard P, Brooks NA, Colclough N, Girdwood A, Hancox UJ, Jones O, Jude D, Loddick SA, Mortlock AA: Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer. Bioorg Med Chem Lett. 2011, 21 (18): 5442-5445. 10.1016/j.bmcl.2011.06.122.
Article
CAS
PubMed
Google Scholar
Loddick SA, Ross SJ, Thomason AG, Robinson DM, Walker GE, Dunkley TP, Brave SR, Broadbent N, Stratton NC, Trueman D, Mouchet E, Shaheen FS, Jacobs VN, Cumberbatch M, Wilson J, Jones RD, Bradbury RH, Rabow A, Gaughan L, Womack C, Barry ST, Robson CN, Critchlow SE, Wedge SR, Brooks AN: AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo. Mol Cancer Ther. 2013, 12 (9): 1715-1727. 10.1158/1535-7163.MCT-12-1174.
Article
CAS
PubMed
PubMed Central
Google Scholar
Omlin AG, Jones RJ, van der Noll R, Graham J, Ong M, Finkelman RD, Schellens JH, Zivi A, Crespo M, Clack G, Alumkal JJ, Dymond A, Dickinson A, Ranson M, Malone M, De Bono JS, Elliott T: A first-in-human study of the oral selective androgen receptor down-regulating drug (SARD) AZD3514 in patients with castration-resistant prostate cancer (CRPC). J Clin Oncol. 2013, 31 (Supplement): 4511-
Google Scholar
Tibbe AG, de Grooth BG, Greve J, Dolan GJ, Terstappen LW: Imaging technique implemented in Cell Tracks system. Cytometry. 2002, 47 (4): 248-255. 10.1002/cyto.10085.
Article
PubMed
Google Scholar
de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008, 14 (19): 6302-6309. 10.1158/1078-0432.CCR-08-0872.
Article
CAS
PubMed
Google Scholar
Miller MC, Doyle GV, Terstappen LW: Significance of Circulating Tumor Cells Detected by the Cell Search System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J Oncol. 2010, 2010: 617421-
Article
PubMed
Google Scholar
Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D, Heller G: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol. 2009, 10 (3): 233-239. 10.1016/S1470-2045(08)70340-1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C, Paterlini-Brechot P: Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol. 2000, 156 (1): 57-63. 10.1016/S0002-9440(10)64706-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cummings J, Raynaud F, Jones L, Sugar R, Dive C: Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer. 2010, 103 (9): 1313-1317. 10.1038/sj.bjc.6605910.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cummings J, Ward TH, Greystoke A, Ranson M, Dive C: Biomarker method validation in anticancer drug development. Br J Pharmacol. 2008, 153 (4): 646-656. 10.1038/sj.bjp.0707441.
Article
CAS
PubMed
Google Scholar
Cummings J, Morris K, Zhou C, Sloane R, Lancashire M, Morris D, Bramley S, Krebs M, Khoja L, Dive C: Method validation of circulating tumour cell enumeration at low cell counts. BMC Cancer. 2013, 13 (1): 415-423.
Article
PubMed
PubMed Central
Google Scholar
Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Menaurement. 1960, 20 (1): 37-46. 10.1177/001316446002000104.
Article
Google Scholar
Hoffman D: Statistical considerations for assessment of bioanalytical incurred sample reproducibility. Aaps J. 2009, 11 (3): 570-580. 10.1208/s12248-009-9134-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cummings J, Zhou C, Dive C: Application of the beta-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assays. J Chromatogr B Analyt Technol Biomed Life Sci. 2011, 879 (13–14): 887-893.
Article
CAS
PubMed
Google Scholar
Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J: PC3 is a cell line characteristic of prostatic small cell carcinoma. The Prostate. 2011, 71 (15): 1668-1679. 10.1002/pros.21383.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gnanapragasam VJ, McCahy PJ, Neal DE, Robson CN: Insulin-like growth factor II and androgen receptor expression in the prostate. BJU international. 2000, 86 (6): 731-735.
Article
CAS
PubMed
Google Scholar
Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004, 10 (20): 6897-6904. 10.1158/1078-0432.CCR-04-0378.
Article
PubMed
Google Scholar
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33 (1): 159-174. 10.2307/2529310.
Article
CAS
PubMed
Google Scholar
Kraan J, Sleijfer S, Strijbos MH, Ignatiadis M, Peeters D, Pierga JY, Farace F, Riethdorf S, Fehm T, Zorzino L, Tibbe AG, Maestro M, Gisbert-Criado R, Denton G, de Bono JS, Dive C, Foekens JA, Gratama JW: External quality assurance of circulating tumor cell enumeration using the Cell Search((R)) system: a feasibility study. Cytometry B Clin Cytom. 2011, 80 (2): 112-118.
Article
PubMed
Google Scholar
Cummings J, Ward TH, Dive C: Fit-for-purpose biomarker method validation in anticancer drug development. Drug Discov Today. 2010, 15 (19–20): 816-825.
Article
CAS
PubMed
Google Scholar
Lee JW, Devanarayan V, Barrett YC, Weiner R, Allinson J, Fountain S, Keller S, Weinryb I, Green M, Duan L, Rogers JA, Millham R, O'Brien PJ, Sailstad J, Khan M, Ray C, Wagner JA: Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res. 2006, 23 (2): 312-328. 10.1007/s11095-005-9045-3.
Article
CAS
PubMed
Google Scholar
Jennings L, Van Deerlin VM, Gulley ML: Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med. 2009, 133 (5): 743-755.
PubMed
Google Scholar
Dunstan RW, Wharton KA, Quigley C, Lowe A: The use of immunohistochemistry for biomarker assessment–can it compete with other technologies?. Toxicol Pathol. 2011, 39 (6): 988-1002. 10.1177/0192623311419163.
Article
PubMed
Google Scholar
Fandel TM, Pfnur M, Schafer SC, Bacchetti P, Mast FW, Corinth C, Ansorge M, Melchior SW, Thuroff JW, Kirkpatrick CJ, Lehr HA: Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol. 2008, 216 (2): 193-200. 10.1002/path.2395.
Article
CAS
PubMed
Google Scholar
Hamilton PW, van Diest PJ, Williams R, Gallagher AG: Do we see what we think we see? The complexities of morphological assessment. J Pathol. 2009, 218 (3): 285-291. 10.1002/path.2527.
Article
PubMed
Google Scholar
Fast DM, Kelley M, Viswanathan CT, O'Shaughnessy J, King SP, Chaudhary A, Weiner R, DeStefano AJ, Tang D: Workshop report and follow-up–AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples–implications of Crystal City recommendations. Aaps J. 2009, 11 (2): 238-241. 10.1208/s12248-009-9100-9.
Article
PubMed
PubMed Central
Google Scholar
Viswanathan CT, Bansal S, Booth B, Destefano AJ, Rose MJ, Sailstad J, Shah VP, Skelly JP, Swann PG, Weiner R: Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays. Pharm Res. 2007, 24 (10): 1962-1973. 10.1007/s11095-007-9291-7.
Article
CAS
PubMed
Google Scholar
Miller KJ, Bowsher RR, Celniker A, Gibbons J, Gupta S, Lee JW, Swanson SJ, Smith WC, Weiner RS: Workshop on bioanalytical methods validation for macromolecules: summary report. Pharm Res. 2001, 18 (9): 1373-1383. 10.1023/A:1013062600566.
Article
CAS
PubMed
Google Scholar
Tibbe AG, Miller MC, Terstappen LW: Statistical considerations for enumeration of circulating tumor cells. Cytometry A. 2007, 71 (3): 154-162.
Article
PubMed
Google Scholar
Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F: Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer. 2011, 105 (9): 1338-1341. 10.1038/bjc.2011.405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ma YC, Wang L, Yu FL: Recent Advances and Prospects in the Isolation by Size of Epithelial Tumor Cells (ISET) Methodology. Technol Cancer Res Treat. 2013, 12 (4): 295-309.
PubMed
Google Scholar
Weinberg RA: Twisted epithelial-mesenchymal transition blocks senescence. Nature Cell Biology. 2008, 10 (9): 1021-1023. 10.1038/ncb0908-1021.
Article
CAS
PubMed
Google Scholar
Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, Board R, Clack G, Hughes A, Blackhall F, Valle JW, Dive C: A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012, 106 (3): 508-516. 10.1038/bjc.2011.545.
Article
CAS
PubMed
Google Scholar
Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, Molina T, Vignaud JM, Flejou JF, Lantuejoul S, Piaton E, Butori C, Mourad N, Poudenx M, Bahadoran P, Sibon S, Guevara N, Santini J, Venissac N, Mouroux J, Vielh P, Hofman PM: Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol. 2011, 135 (1): 146-156. 10.1309/AJCP9X8OZBEIQVVI.
Article
PubMed
Google Scholar